Codiak BioSciences, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four
Codiak BioSciences, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Four of $7.02 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2022-11-03
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.02M.
- 2022-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.02M.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.02M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $6.82M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2022-09-30 | $7.02M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.02M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $7.02M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.82M 10-K · filed 2022-03-10 |
| 2021-09-30 | $6.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.69M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $34.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.50M 10-K · filed 2021-03-17 |
| 2020-09-30 | $6.50M 10-Q · filed 2020-11-19 |